Chemistry:2-Bromo-4,5-methylenedioxyamphetamine

From HandWiki

6-Bromo-MDA, also known as 6-bromo-3,4-methylenedioxyamphetamine or as 2-bromo-4,5-methylenedioxyamphetamine (2-bromo-4,5-MDA), is a psychoactive drug of the phenethylamine, amphetamine, and MDxx families related to 3,4-methylenedioxyamphetamine (MDA).[1][2] It is the 6-bromo derivative of MDA.[1] In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists 6-bromo-MDA's dose as 350 mg orally and its duration as unknown.[1] 6-Bromo-MDA has been reported to produce amphetamine-like effects with no other details provided.[1] However, Daniel Trachsel reported that 6-bromo-MDA was inactive at doses of up to 350 mg.[2] The chemical synthesis of 6-bromo-MDA has been described.[1] 6-Bromo-MDA was first described in the scientific literature by Silvia Sepaveda and colleagues by 1972.[2][3] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]

See also

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. http://www.erowid.org/library/books_online/pihkal/pihkal.shtml.  https://www.erowid.org/library/books_online/pihkal/pihkal019.shtml
  2. 2.0 2.1 2.2 (in de) Phenethylamine: von der Struktur zur Funktion. Nachtschatten-Science (1 ed.). Solothurn: Nachtschatten-Verlag. 2013. pp. 830–830. ISBN 978-3-03788-700-4. OCLC 858805226. https://books.google.com/books?id=-Us1kgEACAAJ. 
  3. "Potential psychotomimetics. New bromoalkoxyamphetamines". J Med Chem 15 (4): 413–415. April 1972. doi:10.1021/jm00274a022. PMID 5019563.